Schedule 13G ownership disclosure
Atossa Therapeutics Inc
Security class unavailable · CUSIP: 04962H506
Event date: 2020-12-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-20-044585
- Form type
- SC 13G
- Filer
- ATOSSA THERAPEUTICS, INC.
- CIK
- CIK 1488039
- Filed
- Dec 28, 2020
- Reporting period
- Dec 17, 2020
- Description
- Schedule 13G beneficial ownership